to-BBB's Series C Round

to-BBB raised a round of funding on June 30, 2014.

to-BBB is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs w…

Articles about to-BBB's Series C Round: